Dergiler / Gazi University Journal of Science / 2026 / Volume: 39 Issue: 3

Hydrothermal synthesis of silver vanadate nanoparticles, antimicrobial and anti-inflammatory potentials, cytotoxicity and interference on the activity of antimicrobial drugs

Juliane Zacour Marinho(State University of Campinas)0000-0002-7865-9409
Isabela Pena Ceravolo(Rene Rachou Institute, Oswaldo Cruz Foundation)0000-0002-1374-2703
Lucas Leão Nascimento(Federal University of Uberlândia)0000-0002-7777-2864
Sayfa
—
Yayın Tarihi
2026-09-01
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Our findings suggest that SVM is a promising candidate for combination therapy, warranting further investigation with surface-functionalized formulations to improve its selectivity.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Bacterial resistance to antimicrobial drugs represents a critical threat to global health, compromising the efficacy of standard therapies.
📊
Temel Bulgular & Veri:SVMs were active against all tested isolates, with MIC values of 128 µg/mL for S. aureus and 256 µg/mL for Gram-negative species.
💡
Sonuç & Katkı:Our findings suggest that SVM is a promising candidate for combination therapy, warranting further investigation with surface-functionalized formulations to improve its selectivity.
🔬Tür:Research Article
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Silver vanadate · Nanoparticles · Antimicrobial

Abstract

Bacterial resistance to antimicrobial drugs represents a critical threat to global health, compromising the efficacy of standard therapies. In this study, we evaluated the antimicrobial properties of silver vanadate microrods (SVMs) against clinical isolates of Staphylococcus aureus, Escherichia coli , and Pseudomonas aeruginosa . SVMs were active against all tested isolates, with MIC values of 128 µg/mL for S. aureus and 256 µg/mL for Gram-negative species. Notably, checkerboard assays revealed synergistic interactions with azithromycin, clindamycin, and sulfamethoxazole (FICi 0.093-0.125), indicating that SVM might potentiate the activity of antimicrobial drugs. The MBC/MIC ratio classified SVM as bactericidal against Gram-negative isolates and bacteriostatic against S. aureus . Scanning electron microscopy suggested a membrane disruption mechanism by a direct nanoparticle-bacteria interaction. SVM also exhibited anti-inflammatory activity comparable to tenoxicam in vitro. SVM presented cytotoxicity to BGM cells at 3.13 µg/mL (CC 50 ). Our findings suggest that SVM is a promising candidate for combination therapy, warranting further investigation with surface-functionalized formulations to improve its selectivity.

🔖

Bu Makaleye Atıf Yap

Marinho, J. Z., Machado, L. F. C., Ceravolo, I. P., Nascimento, L. L., Patrocínio, A. O. D. T., Souza, M. V. D. (2026). Hydrothermal synthesis of silver vanadate nanoparticles, antimicrobial and anti-inflammatory potentials, cytotoxicity and interference on the activity of antimicrobial drugs. Gazi University Journal of Science, Volume: 39 Issue: 3. https://doi.org/10.35378/gujs.1873395

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (47)

  1. Dias-Souza, M.V., Perpétuo, A.A., dos Santos, G.S., Machado, L.F.C. and dos Santos, R.M., “Natural products in drug discovery: Meeting the urgency for new antimicrobials for human and veterinary use”, AIMS Molecular Science, 10: 11-21, (2023). DOI: https://doi.org/10.3934/molsci.2023002
  2. Huemer, M., Mairpady Shambat, S., Brugger, S.D. and Zinkernagel, A.S., “Antibiotic resistance and persistence-Implications for human health and treatment perspectives”, EMBO Reports, 21(12): e51034, (2020). DOI: https://doi.org/10.15252/embr.202051034
  3. Giulieri, S.G., Leroi, M., Daniel, D., Chean, R., Bond, K., Walker, H., Holmes, N.E., Mothobi, N., Alexander, A., Jenney, A., Beckett, C., Mahony, A., Stevens, K., Sherry, N.L., and Howden, B.P., “A multi-hospital, clinician-initiated bacterial genomics programme to investigate treatment failure in severe Staphylococcus aureus infections”, Nature Communications, 16: 4869, (2025). DOI: https://doi.org/10.1038/s41467-025-60045-4
  4. World Bank Group, “Antimicrobial resistance (AMR)”, World Bank Report, Washington, (2025).
  5. Lin, D., Du, S., Zhao, Z., Zhang, T., Wang, L., Zhang, Q., Zhou, S.Y., Graham, D.W., Tissue, D.T., Zhu, D., Zhu, Y.G., Penuelas, J., and Reich, P.B., “Climate warming fuels the global antibiotic resistome by altering soil bacterial traits”, Nature Ecology & Evolution, (2025). DOI: https://doi.org/10.1038/s41559-025-02740-5
  6. GBD 2019 Antimicrobial Resistance Collaborators, “Global mortality associated with 33 bacterial pathogens in 2019: A systematic analysis for the Global Burden of Disease Study 2019”, Lancet, 400(10369): 2221–2248, (2022). DOI: https://doi.org/10.1016/S0140-6736(22)02185-7
  7. Tang, K.W.K., Millar, B.C. and Moore, J.E., “Antimicrobial Resistance (AMR)”, British Journal of Biomedical Science, 80: 11387, (2023). DOI: https://doi.org/10.3389/bjbs.2023.11387
  8. Arulkumaran, N., Routledge, M., Schlebusch, S., Lipman, J. and Conway Morris, A., “Antimicrobial-associated harm in critical care: A narrative review”, Intensive Care Medicine, 46(2): 225–235, (2020). DOI: https://doi.org/10.1007/s00134-020-05929-3
  9. Altammar, K.A., “A review on nanoparticles: Characteristics, synthesis, applications, and challenges”, Frontiers in Microbiology, 14: 1155622, (2023). DOI: https://doi.org/10.3389/fmicb.2023.1155622
  10. Zhang, Y., Zhang, W., Chen, Z., Wang, L. and Yu, G., “Recent developments in polymer semiconductors with excellent electron transport performances”, Chemical Society Reviews, 54(5): 2483–2519, (2025). DOI: https://doi.org/10.1039/d4cs00504j
  11. Tian, B., Xu, S., Rogers, J. A., Cestellos-Blanco, S., Yang, P., Carvalho-de-Souza, J. L., Bezanilla, F., Liu, J., Bao, Z., Hjort, M., Cao, Y., Melosh, N., Lanzani, G., Benfenati, F., Galli, G., Gygi, F., Kautz, R., Gorodetsky, A.A., Kim, S.S., Lu, T.K., Anikeeva P., Cifra, M., Krivosudský, O., Havelka, D., and Jiang, Y., “Roadmap on semiconductor-cell biointerfaces”, Physical biology, 15(3), 031002 (2018). DOI: https://doi.org/10.1088/1478-3975/aa9f34
  12. Ye, L., Hu, R., Liu, L., Liu, J., Liu, J., Chen, H., Hu, Y., Liu, Y., Liu, X., Liu, C., Tng, D.J.H., Meng, Y., Qu, J., Swihart, M.T., and Yong, K.T., “Comparing Semiconductor Nanocrystal Toxicity in Pregnant Mice and Non-Human Primates”, Nanotheranostics, 3(1), 54–65, (2019). DOI: https://doi.org/10.7150/ntno.27452
  13. Konta, R., Kato, H., Kobayashi, H. and Kudo, A., “Photophysical properties and photocatalytic activities under visible light irradiation of silver vanadates”, Physical Chemistry Chemical Physics, 5(14): 3061–3065, (2003). DOI: https://doi.org/10.1039/b300179b
  14. Teixeira, A.B.V., Carvalho-Silva, J.M., Ferreira, I., Schiavon, M.A. and Cândido dos Reis, A., “Silver vanadate nanomaterial incorporated into heat-cured resin and coating in printed resin - Antimicrobial activity in two multi-species biofilms and wettability”, Journal of Dentistry, 145: 104984, (2024). DOI: https://doi.org/10.1016/j.jdent.2024.104984
  15. Carvalho-Silva, J.M. and Reis, A.C., “Systematic review of silver and vanadium-based antibiofilm agents: mechanisms and efficacy in oral biofilms”, Future Microbiology, 20: 639-655, (2025). DOI: https://doi.org/10.1080/17460913.2025.2520080
  16. Mohan, R., Balaji, R., Kaviyarasu, K., Alagarsamy, P. and Geetha, N., “Silver vanadate nanoparticles: Green synthesis, characterization, and antimicrobial activity against multidrug-resistant pathogens”, AIP Advances, 14: 085320, (2024). DOI: https://doi.org/10.1063/5.0217829
  17. Le, G.H., Thanh, D.A., Pham, T.T.T., Tran, Q.V., Dao, N.N., Nguyen, K.T. and Quan, T.T.T., “Rapid and efficient removal of azo dye RR195 from textile wastewater using a Z scheme silver vanadate/graphene oxide: Optimization, photocatalytic mechanism, and antibacterial activity”, Journal of Water Process Engineering, 82: 2026, (2026). DOI: https://doi.org/10.1016/j.jwpe.2026.109536
  18. CLSI, “Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically”, 12th ed., CLSI Standard M07, Clinical and Laboratory Standards Institute, (2018).
  19. Mogana, R., Adhikari, A., Tzar, M.N., Ramliza, R. and Wiart, C., “Antibacterial activities of the extracts, fractions and isolated compounds from Canarium patentinervium Miq. against bacterial clinical isolates”, BMC Complementary Medicine and Therapies, 20: 55, (2020). DOI: http://doi.org/10.1186/s12906-020-2837-5
  20. Alcântara, L.K.S., Machado, L.F.C., Ceravolo, I.P., dos Santos, R.M. and Dias-Souza, M.V., “Antibiofilm effect of Moringa oleifera leaf extract against Staphylococcus aureus, cytotoxicity, biochemical aspects, anti-inflammatory potential, and interference on the activity of antimicrobial drugs”, Fabad Journal of Pharmaceutical Sciences, 48(2): 241–254, (2023). DOI: http://doi.org/10.55262/fabadeczacilik.1213447
  21. Borji, S., Shahriarinour, M., Shariati, S., Ranji, N. and Nikpassand, M., “Enhanced therapeutic efficacy of silibinin loaded silica coated magnetic nanocomposites against Pseudomonas aeruginosa in combination with ciprofloxacin and HepG2 cancer cells”, Scientific Reports, 15: 21498, (2025). DOI: http://doi.org/10.1038/s41598-025-07529-x
  22. Osman, M.E., Abo-Elnasr, A.A. and Mohamed, E.T., “Therapeutic potential activity of quercetin complexes against Streptococcus pneumoniae”, Scientific Reports, 14: 12876, (2024). DOI: http://doi.org/10.1038/s41598-024-62782-w
  23. Menezes, B.R.C., Ribas, R.G., Schatkoski, V.M., Montanheiro, T.L.A., Koga-Ito, C.Y. and Thim, G.P., "Synthesis of β-AgVO3 nanowires by hydrothermal and precipitation routes: a comparative study", Discover Applied Sciences, 1: 1327, (2019). DOI: http://doi.org/10.1007/s42452-019-1396-1
  24. Pudukudy, M., Jia, Q., Wang, H., Shan, S. and Rajendran, R., "Influence of synthesis parameters on the crystalline, structural, textural, optical and photocatalytic properties of α and β polymorphs of AgVO3 nanorods". Materials Science in Semiconductor Processing, 107: 104824, (2020). DOI: http://doi.org/10.1016/j.mssp.2019.104824
  25. Ishak, A., Mazonakis, N., Spernovasilis, N., Akinosoglou, K. and Tsioutis, C., “Bactericidal versus bacteriostatic antibacterials: Clinical significance, differences and synergistic potential in clinical practice”, Journal of Antimicrobial Chemotherapy, 80(1): 1-17, (2025). DOI: http://doi.org/10.1093/jac/dkae380
  26. Yin, I.X., Zhang, J., Zhao, I.S., Mei, M.L., Li, Q. and Chu, C.H., “The antibacterial mechanism of silver nanoparticles and its application in dentistry”, International Journal of Nanomedicine, 15: 2555-2562, (2020). DOI: http://doi.org/10.2147/IJN.S246764
  27. Dakal, T.C., Kumar, A., Majumdar, R.S. and Yadav, V., “Mechanistic basis of antimicrobial actions of silver nanoparticles”, Frontiers in Microbiology, 7: 1831, (2016). DOI: http://doi.org/10.3389/fmicb.2016.01831
  28. Koduru, J.R., Kailasa, S.K., Bhamore, J.R., Kim, K.H., Dutta, T. and Vellingiri, K., “Phytochemical-assisted synthetic approaches for silver nanoparticles antimicrobial applications: A review”, Advances in Colloid and Interface Science, 256: 326-339, (2018). DOI: http://doi.org/10.1016/j.cis.2018.03.001
  29. He, J., Ma, Y., Niu, X., Pei, J., Yan, R., Xu, F., Ma, J., Ma, X., Jia, S., and Ma, W., “Silver nanoparticles induce endothelial cytotoxicity through ROS-mediated mitochondria-lysosome damage and autophagy perturbation: The protective role of N-acetylcysteine”, Toxicology, 502: 153734, (2024). DOI: https://doi.org/10.1016/j.tox.2024.153734
  30. de Campos, M.R., Botelho, A.L. and dos Reis, A.C., “Nanostructured silver vanadate decorated with silver particles and their applicability in dental materials: A scope review”, Heliyon, 7(6): e07168, (2021). DOI: http://doi.org/10.1016/j.heliyon.2021.e07168
  31. Holtz, R.D., Lima, B.A., Souza Filho, A.G., Brocchi, M. and Alves, O.L., “Nanostructured silver vanadate as a promising antibacterial additive to water-based paints”, Nanomedicine, 8(6): 935-940, (2012). DOI: http://doi.org/10.1016/j.nano.2011.11.012
  32. Essghaier, B., Hannachi, H., Nouir, R., Mottola, F. and Rocco, L., “Green synthesis and characterization of novel silver nanoparticles using Achillea maritima subsp. maritima aqueous extract: Antioxidant and antidiabetic potential and effect on virulence mechanisms of bacterial and fungal pathogens”, Nanomaterials, 13: 1964, (2023). DOI: http://doi.org/10.3390/nano13131964
  33. Assis, M., Silva, J.S., Gonçalves, M.O., Rodolpho, J.M.A., Fragelli, B.D.L., Corte, A.B.P., Ribeiro, L.K., Teodoro, M.D., Anibal, F.F., Sousa, C.P., Oliveira Jr., O.N., Andrés, J. and Longo, E., "Bactericidal activity of Ag4V2O7/β-AgVO3 heterostructures against antibiotic-resistant Klebsiella pneumoniae", Biomaterials Advances, 141: 213097, (2022). DOI: http://doi.org/10.1016/j.bioadv.2022.213097
  34. de Castro, D.T., Valente, M.L.C., da Silva, C.H.L., Watanabe, E., Siqueira, R.L., Schiavon, M.A., Alves, O.L. and dos Reis, A.C., “Evaluation of antibiofilm and mechanical properties of new nanocomposites based on acrylic resins and silver vanadate nanoparticles”, Archives of Oral Biology, 67: 46-53, (2016). DOI: http://doi.org/10.1016/j.archoralbio.2016.03.002
  35. Mohan, R., Balaji, R., Kaviyarasu, K., Alagarsamy, P. and Geetha, N., “Silver vanadate nanoparticles: Green synthesis, characterization, and antimicrobial activity against multidrug-resistant pathogens”, AIP Advances, 14(8): 085320, (2024). DOI: http://doi.org/10.1063/5.0223155
  36. Das, B., Dash, S.K., Mandal, D., Ghosh, T., Chattopadhyay, S., Tripathy, S., Das, S., Dey, S.K., Das, D. and Roy, S., "Green synthesized silver nanoparticles destroy multidrug resistant bacteria via reactive oxygen species mediated membrane damage", Arabian Journal of Chemistry, 10(6): 862–876, (2017). DOI: http://doi.org/10.1016/j.arabjc.2015.08.008
  37. Alotaibi, A.M., Alsaleh, N.B., Aljasham, A.T., Tawfik, E.A., Almutairi, M.M., Assiri, M.A., Alkholief, M. and Almutairi, M.M., "Silver nanoparticle-based combinations with antimicrobial agents against antimicrobial-resistant clinical isolates", Antibiotics, 11(9): 1219, (2022). DOI: http://doi.org/10.3390/antibiotics11091219
  38. Khan, F., Ahmad, I., Rahman, M., Shakil, S. and Mushtaq, S., “Novel silver nanoparticle-antibiotic combinations as promising antibacterial and anti-biofilm candidates against multiple-antibiotic resistant ESKAPE microorganisms”, Colloids and Surfaces B: Biointerfaces, 231: 113826, (2024). DOI: http://doi.org/10.1016/j.colsurfb.2023.113826
  39. Leal, W.S., Marinho, J.Z., Ceravolo, I.P., Nascimento, L.L., Patrocínio, A.O.T. and Dias-Souza, M.V., "Antimicrobial and anti-inflammatory potentials of silver tungstate nanoparticles, cytotoxicity and interference on the activity of antimicrobial drugs", Drugs and Drug Candidates, 4(3): 30, (2025). DOI: http://doi.org/10.3390/ddc4030030
  40. Webel, H.E., Kimber, T.B., Radetzki, S., Neuenschwander, M., Nazaré, M. and Volkamer, A., "Revealing cytotoxic substructures in molecules using deep learning", Journal of Computer-Aided Molecular Design, 34(7): 731–746, (2020). DOI: https://doi.org/10.1007/s10822-020-00310-4
  41. Pimentel, B.N.A.S., De Annunzio, S.R., Assis, M., Barbugli, P.A., Longo, E. and Vergani, C.E., "Biocompatibility and inflammatory response of silver tungstate, silver molybdate, and silver vanadate microcrystals", Frontiers in Bioengineering and Biotechnology, 11: 1215438, (2023). DOI: https://doi.org/10.3389/fbioe.2023.1215438
  42. Teixeira, A.B.V., de Castro, D.T., Schiavon, M.A. and dos Reis, A.C., “Cytotoxicity and release ions of endodontic sealers incorporated with a silver and vanadium base nanomaterial”, Odontology, 108(4): 661-668, (2020). DOI: http://doi.org/10.1007/s10266-020-00507-x.
  43. Teixeira, A.B.V., Moreira, N.C.S., Takahashi, C.S., Schiavon, M.A., Alves, O.L. and Reis, A.C., "Cytotoxic and genotoxic effects in human gingival fibroblast and ions release of endodontic sealers incorporated with nanostructured silver vanadate", Journal of Biomedical Materials Research Part B: Applied Biomaterials, 109(9): 1380–1388, (2021). DOI: https://doi.org/10.1002/jbm.b.34798
  44. Carvalho-Silva, J.M. and Reis, A.C.D., “Anti-inflammatory action of silver nanoparticles in vivo: Systematic review and meta-analysis”, Heliyon, 10(14): e34564, (2024). DOI: http://doi.org/10.1016/j.heliyon.2024.e34564
  45. El-Deeb, N.M., Abo-Eleneen, M.A., Al-Madboly, L.A., Sharaf, M.M., Othman, S.S., Ibrahim, O.M. and Mubarak, M.S., "Biogenically synthesized polysaccharides-capped silver nanoparticles: immunomodulatory and antibacterial potentialities against resistant Pseudomonas aeruginosa", Frontiers in Bioengineering and Biotechnology, 8: 643, (2020). DOI: https://doi.org/10.3389/fbioe.2020.00643
  46. Ferreira, S.R., Lopes, J.M., Paterno, L.G., Magalhães, P.O., Cunha-Filho, M., Gelfuso, G.M. and Gratieri, T., "Colloidal copper oxide nanoparticles leading to a biphasic dose-response in growth inhibition of Staphylococcus aureus", Future Microbiology, 18: 471–479, (2023). DOI: https://doi.org/10.2217/fmb-2022-0250
  47. Bélteky, P., Rónavári, A., Igaz, N., Szerencsés, B., Tóth, I.Y., Pfeiffer, I., Kiricsi, M. and Kónya, Z., "Silver nanoparticles: aggregation behavior in biorelevant conditions and its impact on biological activity", International Journal of Nanomedicine, 14: 667–687, (2019). DOI: https://doi.org/10.2147/IJN.S185965